Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CALAA-01

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Significance CALAA-01 is a targeted nanoparticle containing siRNA that is a first-in-class experimental therapeutic for cancer… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
siRNA clinical trials: state of the art With the emergence of siRNA-based nanomedicine as a powerful therapeutic strategy for… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
The approval of drugs for human use by the US Food and Drug Administration (FDA) through the Center for Drug Evaluation and… Expand
Is this relevant?
2010
2010
  • V. Brower
  • Journal of the National Cancer Institute
  • 2010
  • Corpus ID: 41804915
S ince the discovery of RNA interference (RNAi) in 1998, researchers have hoped to use the gene-silencing technique to shut down… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
  • M. Davis
  • Molecular pharmaceutics
  • 2009
  • Corpus ID: 22164615
Experimental therapeutics developed to exploit RNA interference (RNAi) are now in clinical studies. Here, the translation from… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?